Pharmacokinetic Study of a Fixed Dose Combination Nefopam Hydrochloride (30 mg) / Paracetamol (500 mg)

NCT05129137 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: nefopam hydrochloride 30mg X2
DRUG: paracetamol 500 mg X2
DRUG: Combination Product: nefopam hydrochloride 30mg / paracetamol 500mg X2

Sponsor

Unither Pharmaceuticals, France

Collaborators

[object Object]